These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27986142)

  • 21. Actinic keratosis on a continuum with squamous cell carcinoma.
    Hurwitz RM; Buckel LJ
    Arch Dermatol; 2010 Aug; 146(8):923-4. PubMed ID: 20713835
    [No Abstract]   [Full Text] [Related]  

  • 22. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.
    Verneuil L; Leboeuf C; Bousquet G; Brugiere C; Elbouchtaoui M; Plassa LF; Peraldi MN; Lebbé C; Ratajczak P; Janin A
    Oncotarget; 2015 Dec; 6(39):41497-507. PubMed ID: 26594799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Timing and Number of Cutaneous Squamous Cell Carcinomas in Transplant Recipients.
    Puza CJ; Cardones AR; Mosca PJ
    JAMA Dermatol; 2018 Jun; 154(6):727-728. PubMed ID: 29799959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging drugs for actinic keratosis.
    Ulrich M; Drecoll U; Stockfleth E
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):545-55. PubMed ID: 20670178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology and risk factors for multiple squamous cell carcinomas in a cohort of organ transplant recipients from northern Italy: a single center study.
    Zavattaro E; Veronese F; Airoldi C; DI Cristo N; Savoia P
    Ital J Dermatol Venerol; 2023 Oct; 158(5):379-387. PubMed ID: 37916398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Actinic keratosis: facts and controversies.
    Ko CJ
    Clin Dermatol; 2010; 28(3):249-53. PubMed ID: 20541675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body-site distribution of skin cancer, pre-malignant and common benign pigmented lesions excised in general practice.
    Youl PH; Janda M; Aitken JF; Del Mar CB; Whiteman DC; Baade PD
    Br J Dermatol; 2011 Jul; 165(1):35-43. PubMed ID: 21443534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of skin cancers in liver and renal transplant recipients: Results of a prospective study in an Australian tertiary referral centre.
    Ge L; Chee SN; Robledo KP; Lowe P
    Australas J Dermatol; 2018 Nov; 59(4):291-296. PubMed ID: 29292515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dermoscopy of actinic keratosis, intraepidermal carcinoma and squamous cell carcinoma.
    Zalaudek I; Argenziano G
    Curr Probl Dermatol; 2015; 46():70-6. PubMed ID: 25561209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantifying Actinic Keratosis Transformation Using a Risk Analysis Calculator.
    Ravishankar A; Maher IA; Gravely AA; Goldfarb NI
    Dermatol Surg; 2021 Jan; 47(1):141-144. PubMed ID: 31634255
    [No Abstract]   [Full Text] [Related]  

  • 31. [The real face of actinic keratosis: field of cancerisation and squamous cell carcinoma].
    Basset-Seguin N
    Eur J Dermatol; 2012 Dec; 22 Suppl 1():5-9. PubMed ID: 23269757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Actinic keratosis: precancer, squamous cell carcinoma, or marker of field cancerization?
    Deltondo JA; Helm KF
    G Ital Dermatol Venereol; 2009 Aug; 144(4):441-4. PubMed ID: 19755947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haptoglobin polymorphism and the risk of actinic keratoses and cutaneous squamous cell carcinoma: A case-control study.
    Brochez L; Speeckaert R; De Bacquer D; Delanghe J; Hoorens I
    J Dermatol; 2019 Mar; 46(3):274-275. PubMed ID: 30614562
    [No Abstract]   [Full Text] [Related]  

  • 34. Is tenderness a reliable predictor for differentiating squamous cell carcinomas from actinic keratoses?
    Cook BA; Gravely AA; Nelson DB; Warshaw EM
    J Am Acad Dermatol; 2011 Jul; 65(1):211-2. PubMed ID: 21679820
    [No Abstract]   [Full Text] [Related]  

  • 35. The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark.
    Li H; Pedersen L; Nørgaard M; Ulrichsen SP; Thygesen SK; Nelson JJ
    BMC Cancer; 2016 May; 16():295. PubMed ID: 27141983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The many clinico-pathologic faces of actinic keratosis: an atlas.
    Massone C; Cerroni L
    Curr Probl Dermatol; 2015; 46():64-9. PubMed ID: 25561208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects.
    Reinehr CPH; Bakos RM
    An Bras Dermatol; 2019; 94(6):637-657. PubMed ID: 31789244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actinic keratoses.
    Stockfleth E
    Cancer Treat Res; 2009; 146():227-39. PubMed ID: 19415207
    [No Abstract]   [Full Text] [Related]  

  • 39. What lies beneath actinic keratosis? Looking beyond visible lesions to optimize patient outcomes.
    Lear JT
    J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():3-4. PubMed ID: 28263019
    [No Abstract]   [Full Text] [Related]  

  • 40. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
    Karagece Yalçin U; Seçkın S
    Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.